• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Our Thanks to Reviewers in 2010

Article

At Consultant, our goal is to provide the practical, authoritative information you need to best serve your patients. That is why we "pre-test" article ideas (before we invite articles on those topics) to be sure they are of real interest to you and your colleagues. It is also why we take great care in checking facts, creating useful tables and figures, and choosing illustrations and photographs to enhance teaching messages.

At Consultant, our goal is to provide the practical, authoritative information you need to best serve your patients. That is why we "pre-test" article ideas (before we invite articles on those topics) to be sure they are of real interest to you and your colleagues. It is also why we take great care in checking facts, creating useful tables and figures, and choosing illustrations and photographs to enhance teaching messages.

And it is why all articles we publish must survive peer review not only by the distinguished leaders in primary care who make up our editorial board but also by several specialists and primary care physicians culled from Consultant readers. We ask reviewers to consider whether the discussion is accurate, balanced, complete, and timely; the drug regimens are reasonable; controversies are fairly outlined; the clinical advice is clear; and the recommended diagnostic and therapeutic measures are widely available in the community.

The questions these reviewers pose help the authors and staff keep Consultant squarely focused on your educational needs.

In this, the last issue of our 50th year of publication, we want to extend our thanks to the following reviewers who appraised at least one manuscript for us in 2010.

Navin M. Amin, MD Sandra L. Argenio, MD Richard Balon, MD Kirk Barber, MD J. David Beckham, MD Gerald Bernstein, MD Henry R. Black, MD Robert P. Blereau, MD William J. Brady, MD Charles S. Bryan, MD R. Michael Buckley, MD Lee S. Caplan, MD, PhD Roberto Cardarelli, DO, MPH Mercedes R. Carnethon, PhD Michael B. Chancellor, MD Rachmel Cherner, MD John F. Connolly, MD Mary E. Costanza, MD David Effron, MD S. Ather Enam, MD, PhD Richard G. Farmer, MD Faith T. Fitzgerald, MD Peter Frank, DO David R. Garr, MD Paul Gleich, MD Ladan Golestaneh, MD Caron M. Grin, MD Michael E. Hagensee, MD, PhD Gregory S. Harmon, MD Richard Harrigan, MD Warren A. Heffron, MD Jorge L. Herrera, MD Russell J. Hopp, DO Grace Brooke Huffman, MD Ben Huneycutt, MD Steve Iliffe, FRCGP Jonathan S. Ilowite, MD Mohit Jain, MD Kenar D. Jhaveri, MD Melissa Jones, PharmD Deepak M. Kamat, MD, PhD David L. Kaplan, MD Lawrence I. Kaplan, MD Jeffrey T. Kirchner, MD Harvey M. Kramer, MD Robert E. Leach, MD Edgar V. Lerma, MD Alexander K. C. Leung, MD Joseph A. Lieberman III, MD, MPH Richard Y. McConnell, MD Eugene Mochan, PhD, DO
Prashanth R. Mopala, MD John Mosby, MD Dale P. Murphy, MD Anita Nelson, MD David B. Nash, MD, MBA David T. Nash, MD Morris Papernik, MD Jacqueline G. Parthemore, MD Thomas L. Petty, MD Michael F. Picco, MD, PhD Susan M. Pollart, MD, MS D. Brady Pregerson, MD L. Michael Prisant, MD Robert E. Rakel, MD Sujatha Ramesh, MD Robert E. Reisman, MD Wayne Reynolds, DO Dale Rice, MD Diana Rinkevich, MD Robert J. Rogers, MD, FACP Ted Rosen, MD Marti Jill Rothe, MD Ronald N. Rubin, MD Gary E. Ruoff, MD Gregory W. Rutecki, MD Joseph D. Schmidt, MD Robert T. Segraves, MD, PhD Timothy H. Self, PharmD Edward J. Shahady, MD Leonid Skorin Jr, DO Clark Smith, MD Christopher Snell, PhD Andr N. Sofair, MD Todd P. Stitik, MD Michael B. Strauss, MD Stephen B. Sulavik, MD Nicole Touchet, MD Edward L. Trimble, MD Donald G. Vidt, MD Edward M. Weaver, MD, MPH Michael H. Weisman, MD Stuart Weiss, MD Herbert White, MD, MPH Russell D. White, MD James T. Willerson, MD Robert J. Wolfson, MD William Yaakob, MD Barbara P. Yawn, MD Durgamani K. Yellumahanthi, MD Richard J. Zimmer, DO
Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
FDA Approves Second Generic OTC Naloxone Nasal Spray to Reverse Opioid Overdose / image credit Narcan ©Waldenmarus/stock.adobe.com

FDA Approves Second Generic OTC Naloxone Nasal Spray to Reverse Opioid Overdose

April 26th 2024
Article

The newest generic OTC nonprescription naloxone hydrochloride nasal spray provides additional access to the lifesaving treatment, at potentially lower cost.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight / image credit ©brovarky/stock.adobe.com

Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight

April 25th 2024
Article

Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

FDA Approves First New Antibiotic in Decades for Uncomplicated UTI in Women / image credit fda approval ©Walenmarus/stock.adobe.com

FDA Approves First New Antibiotic in Decades for Uncomplicated UTI

April 25th 2024
Article

Pivmecillinam is an aminopenicillin, a class of beta-lactam antibiotics with a mechanism of action that may help reduce rising levels of antibiotic resistance.

Food vs Medicine for IBS: Dietary Measures First, New Study Suggests / image credit IBS ©Yurii Kibalnik/stock.adobe.com

Food vs Medicine for IBS: Dietary Measures First, New Study Suggests

April 25th 2024
Article

More participants consuming either of 2 common IBS dietary regimens experienced significant and sustained symptom relief vs those given pharmacotherapy.

© 2024 MJH Life Sciences

All rights reserved.